Abstract

Background: The treatment and prognosis for muscle-invasive bladder cancer (MIBC) and non-muscle-invasive bladder cancer (NMIBC) are different. We aimed to construct a nomogram based on the multiparametric MRI (mpMRI) radiomics signature and the Vesical Imaging-Reporting and Data System (VI-RADS) score for the preoperative differentiation of MIBC from NMIBC. Methods: The retrospective study involved 185 pathologically confirmed bladder cancer (BCa) patients who received mpMRI before surgery between August 2014 to April 2020. A total of 2,436 radiomics features were quantitatively extracted from the largest lesion located on the axial T2WI and from dynamic contrast-enhancement images. After feature selection, radiomics signatures were developed in the training set (n=129) and validated in the validation set (n=56) . Univariable and multivariable logistic regression were used to develop a nomogram. Findings: The radiomics signature generated by the least absolute shrinkage and selection operator classifier had the best capacity for muscle-invasive status differentiation in both the training (accuracy: 90.7%, area under the curve (AUC): 0.934) and validation sets (accuracy: 87.5%, AUC: 0.906). Incorporating the radiomics signature and VI-RADS score, the nomogram demonstrated better discrimination and calibration both in the training set (accuracy: 93.0%, AUC: 0.970) and validation set (accuracy: 89.3%, AUC: 0.943). Decision curve analysis showed the clinical usefulness of the nomogram. Interpretation: The mpMRI radiomics signature may be useful for the preoperative differentiation of muscle-invasive status in BCa . The proposed nomogram integrating the radiomics signature with the VI-RADS score may further increase the differentiation power and improve clinical decision making. Funding Statement: Shanghai Science Committee Foundation and Shanghai Youth Science and Technology Talents Sailing Program. Declaration of Interests: This study was funded by the Shanghai Science Committee Foundation (grant number 19411967700) and Shanghai Youth Science and Technology Talents Sailing Program (20YF1437200). Ethics Approval Statement: This study was approved by the institutional review board, and informed consent of patients was waived due to its retrospective nature.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call